جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.
RE

Raghda Eziza

بانتظار توثيق الانتساب2025–2026
2وثائق Scopus
0استشهاداً
0مؤشر h
0منها بانتماء الجامعة
إجمالي Scopus (كل الجهات)
مقالمفتوح (مستودع)2026

Assessment of Health-related Quality of Life and Associated Factors among Healthcare Providers in Riyadh, Saudi Arabia: A Cross-sectional Study

Advanced Health Science and Technology Journal · مجلد 2 (1) · 47-52

Abstract Background: Healthcare providers in Saudi Arabia often neglect their personal health due to high occupational stress and cultural barriers. This study evaluates the Health-Related Quality of Life (HRQoL) among providers in Riyadh and identifies factors influencing their well-being. Methods: A cross-sectional study was conducted among 122 healthcare providers using the validated Arabic and English short form health survey (SF-36) between January and March 2025. Data were analyzed using SPSS v28, employing Kolmogorov-Smirnov tests for normality and Mann-Whitney U tests for group comparisons. Results: Males scored significantly higher in social functioning and emotional well-being ( P < 0.05). Physical functioning significantly decreased with age (p = 0.009). Conclusion: Demographic factors significantly impact HRQoL. Targeted institutional wellness initiatives are essential to support the healthcare workforce.

health-related quality of lifehealthcare workersoccupational stresshealthcare worker well-being
مقالمفتوح (مستودع)2025

Effectiveness of Corticosteroid Therapy in the Management of Chronic Rhinosinusitis among Saudi Patients

Advanced Health Science and Technology Journal · مجلد 1 (2) · 86-91

Abstract Background: Chronic rhinosinusitis (CRS) is a persistent inflammatory disorder of the paranasal sinuses, significantly impairing quality of life (QoL). While corticosteroids are central to CRS management, evidence from Saudi Arabia remains limited. Objectives: This study aimed to (1) evaluate the improvement in CRS symptoms following corticosteroid therapy, (2) compare the effectiveness of intranasal versus systemic corticosteroids, (3) analyze side effects, and (4) assess the impact of therapy on QoL among Saudi patients. Methodology: A cross-sectional descriptive study was conducted among Saudi adults with physician-diagnosed CRS and prior corticosteroid use. Data were collected via an online questionnaire incorporating the validated Sino-Nasal Outcome Test-22. Descriptive and inferential statistics were performed using SPSS. Results: Of 201 participants, 78.6% had a CRS diagnosis and 70.6% used intranasal corticosteroids. Most patients (88.6%) reported moderate-to-complete improvement in symptoms, with intranasal sprays demonstrating significantly greater effectiveness compared to oral corticosteroids ( P < 0.001). Adverse effects were rare, with 95.5% reporting none; headaches (2.5%) and nausea (1.0%) were the most common. Quality-of-life scores improved, although persistent issues included nasal congestion, loss of smell, and daily irritation. Conclusion: Corticosteroid therapy–particularly intranasal sprays–is highly effective and well-tolerated in Saudi patients with CRS. These findings align with global evidence and highlight the need for patient education and improved adherence to optimize outcomes within the Saudi healthcare context.

chronic rhinosinusitiscorticosteroid therapyintranasal corticosteroidssystemic corticosteroids